-The Economic Times Vaccines are a true gift of science to humanity. In developing countries, prevention is better than cure. Vaccines have a great track record of safety and efficacy and they are amongst the most cost-effective products, which even the poor have access to due to effective systems of procurement and delivery. India's contribution in the vaccine arena is noteworthy. The primary reason behind the country's vaccine success story is...
More »SEARCH RESULT
Total Matching Records found : 106
Tuberculosis breakthrough as scientists get funds for 'electronic nose' by Mark Tran
A mobile device that detects TB by 'sniffing' a person's breath will make a huge impact in villages far from health facilities A team of Indian researchers are planning to have a prototype of an "electronic nose" that can detect tuberculosis from a person's breath in hospitals by October 2013, after receiving a $950,000 grant on Monday. Working on the same principles as a breathalyser, the device – if successful – could...
More »Gates Foundation’s AIDS Program in India Has Made Uneven Progress Over 8 Years by Donald G McNeil Jr.
A large and costly AIDS prevention program that the Bill and Melinda Gates Foundation pioneered in India eight years ago has had mixed results, according to a preliminary analysis published on Monday in The Lancet. The foundation spent $258 million on the program from 2003 to 2008. It has since put in $80 million more, but is shifting responsibility to the Indian government. The program, called Avahan, focuses on high-risk groups, like...
More »Who will pay for malaria vaccine? by Sarah Boseley
Malaria is a mass killer, taking just under 800,000 lives a year. Most of them are babies and children under five. A significant number are pregnant women. It is an entirely preventable disease, caused by a parasite transmitted by mosquito bite, but the millions who live under its curse are too poor and have too few options to be able to avoid it. The malaria vaccine [ See: “Malaria vaccine partly...
More »Potential Vaccine Halves Malaria Risk for Children by Elizabeth Whitman
In a major breakthrough Tuesday, researchers announced that the vaccine candidate RTS,S reduces the risk of malaria by half in children ages five to 17 months, first results from a continuing phase three trial showed. The results have tremendous implications, as malaria is responsible for nearly 800,000 deaths annually. The disease kills one child every 45 seconds in Africa, where it accounts for approximately 20 percent of childhood deaths, according to...
More »
